Predicting Rocket Lab (NASDAQ: RKLB) through 2030 requires more than extrapolating its current revenue growth.
Rocket Lab is simultaneously developing Neutron, expanding defense programs, growing Space Systems and pursuing an approximately $8 billion acquisition of Iridium.
The latest operating data show meaningful momentum: Q2 2026 revenue reached approximately $234.1 million, backlog increased to about $2.36 billion, and Q3 revenue guidance was approximately $250 million–$265 million.
However, Rocket Lab remains loss-making, Neutron's maiden flight remains uncertain, and Iridium has not yet closed.
Rather than presenting one precise price target, a better framework is to use Bear, Base and Bull scenarios.
| Year | Bear | Base | Bull |
|---|---|---|---|
| End-2026 | $35–$50 | $55–$80 | $85–$110 |
| End-2027 | $25–$45 | $60–$95 | $110–$160 |
| End-2028 | $20–$45 | $70–$110 | $140–$200 |
| 2030 | $15–$40 | $90–$150 | $180–$300+ |
These ranges are illustrative scenarios created for educational analysis, not analyst consensus targets.
Unlike Sharplink or a crypto treasury company, Rocket Lab is better analyzed through operating fundamentals.
A simplified model is:
Launch Revenue
Space Systems Revenue
Defense Revenue
Potential Iridium Services Revenue
↓
Future Revenue / EBITDA / Cash Flow
×
Valuation Multiple
↓
Equity Value
÷
Diluted Shares
↓
Implied RKLB Price
Electron is Rocket Lab's proven launch vehicle.
Continued launch growth can improve:
But Electron alone is unlikely to justify the entire long-term bull case.
Neutron could change the scale of Rocket Lab's launch opportunity.
Rocket Lab targets up to 13,000 kg to LEO with a reusable first stage.
The issue is timing.
As of August 2026, the first vehicle is targeted to reach the pad in Q4, while management acknowledges that the window for a maiden flight before year-end has narrowed.
This makes Neutron a major forecast variable.
Rocket Lab's July 2026 $266 million Space Force contract shows that defense programs can become material revenue drivers.
Continued success in:
could support higher long-term revenue.
Rocket Lab's Q2 product revenue reached approximately $181.3 million, demonstrating how important spacecraft and hardware have become relative to launch alone.
If Space Systems continues scaling, Rocket Lab can grow even before Neutron reaches high cadence.
Iridium is potentially transformative.
The pending transaction would bring a business that generated $871.7 million of 2025 revenue and approximately $495 million OEBITDA, according to Rocket Lab's acquisition announcement.
If successfully completed and integrated, Rocket Lab could gain:
If the transaction fails or integration performs poorly, the valuation impact could be very different.
Rocket Lab uses equity for:
Iridium specifically includes RKLB shares in the consideration.
Future stock-price growth therefore depends partly on:
business-value growth per diluted share
not just total company revenue.
Possible conditions:
This scenario does not require Rocket Lab's core business to collapse.
Possible assumptions:
Likely requires:
2027 may be a decisive year.
The key questions could include:
Reflects prolonged Neutron problems and acquisition concerns.
Assumes steady execution.
Requires successful Neutron commercialization plus favorable Iridium progress.
By 2028, investors may care less about “first flight” and more about:
The illustrative base range is $70–$110.
The bull case reaches $140–$200 if Rocket Lab establishes itself as a scaled vertically integrated space company.
Possible reasons:
This scenario assumes:
This scenario would require Rocket Lab to become a much larger space platform.
Likely assumptions:
This is a high-execution scenario, not a target.
A high-growth space company can trade at a large revenue multiple when investors expect:
But multiples can contract rapidly.
Even strong revenue growth may not prevent RKLB from falling if the valuation investors assign to each dollar of revenue declines.
RKLBON is designed to track economic exposure linked to RKLB.
Therefore, broadly bullish or bearish RKLB scenarios should influence RKLBON.
But it is inappropriate to assume:
RKLB at $100 = RKLBON exactly 100 USDT at every moment.
Differences can result from:
Ondo's arbitrage and backing mechanisms are designed to support tracking, but temporary price dislocations can occur.
It is possible within the illustrative base-to-bull scenarios, but there is no guarantee.
A valuation above $200 per share would likely require substantial success from Neutron, Space Systems, defense and/or Iridium.
Yes. Growth stocks can experience major valuation compression, particularly when key programs are delayed.
Neutron is one of the most important organic catalysts, while Iridium is the most significant pending strategic transaction.
Rocket Lab currently targets first-vehicle delivery to the pad in Q4 2026, but the maiden-flight date remains uncertain.
No. It is economically linked to RKLB but remains a separate tokenized product.
Through RKLBON/USDT on MEXC.
All future RKLB price ranges in this article are hypothetical scenarios created for educational purposes. They are not analyst consensus estimates, price targets or guarantees.
Actual RKLB prices may fall below or rise above every scenario shown.
Rocket Lab faces launch, Neutron, acquisition, integration, competition, profitability, financing, dilution, defense-contract and valuation risks. RKLBON adds Ondo issuer and backing, tracking, blockchain, liquidity, USDT and MEXC custody risks.

Summary RKLB and RKLBON both provide exposure related to Rocket Lab, but they are fundamentally different products. RKLB is common stock in Rocket Lab Corporation, listed on Nasdaq. RKLBON, styled by

Summary MEXC officially added RKLBON to its Convert service on April 2, 2026. The platform describes Convert as offering zero separate transaction fees, instant conversion and a fixed quoted

Summary RKLBON is designed to track economic exposure linked to Rocket Lab Corporation (NASDAQ: RKLB). The pricing relationship can be simplified as: Rocket Lab fundamentals ↓ RKLB stock price ↓ Ondo

The Federal Reserve just delivered something markets normally dislike: a 25-basis-point interest-rate hike. On September 16, the Fed raised its benchmark rate to 3.75%-4.00%, its first increase since

If you trade regularly on MEXC, you've probably come across oil-related derivatives at some point. But for most crypto traders, oil remains a fairly unfamiliar market, because the forces driving its

The previous session was Thursday, September 17. All three indexes rebounded: the Nasdaq Composite rose 1.69% to 26,418.30, the S&P 500 rose 1.13% to 7,637.05 and the Dow Jones Industrial rose 0.61%

ZEC price has surged above $1,400 as institutional interest, ETF demand and short covering strengthen the Zcash rally. Can it continue?

ARB price has surged 30% as Robinhood Chain turns Arbitrum technology into recurring revenue. Here is what is driving the rally and its risks.

Meta Platforms has never split its stock. Since its May 2012 IPO at $38 per share, first as Facebook under the ticker FB and now as META, the company has completed zero forward splits and zero reverse

Tesla has split its stock twice: a 5-for-1 split with split-adjusted trading starting August 31, 2020, and a 3-for-1 split starting August 25, 2022. Together they produced a cumulative 15-for-1 adjust

Tesla trades as TSLA on the Nasdaq. Most of its revenue comes from selling electric vehicles, so quarterly deliveries and automotive gross margin drive its results — Tesla delivered 480,126 vehicles i